Results
Found 522 hits.
Search Results for: E_S4HCON2023 Übungsmaterialien - E_S4HCON2023 Lernführung: SAP Certified Technology Specialist - SAP S/4HANA Conversion and SAP System Upgrade - E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung – Page 51
Hypersensitivity vasculitis
26. | Maurer, M. and Zuberbier, T.: Hypersensitivity vasculitis. In: Akdis, C. A. and Agache, I., editors: Global atlas of allergy. EAACI, 2014 |
Mast cells – key effector cells in immune responses
17. | Metz, M. and Maurer, M.: Mast cells – key effector cells in immune responses. Trends Immunol. 2007: 28; 234-241. IF: 9.48 |
Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema
128. | Bygum, A., Busse, P., Caballero, T., and Maurer, M.+: Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema. Front. Med. 2017: 4; 212. IF: : 2.03 |
Diagnosis and treatment of urticaria and angioedema: a worldwide perspective
67. | Sánchez-Borges, M., Asero, R., Ansotegui, I. J., Baiardini, I., Bernstein, J. A., Canonica, G. W., Gower, R., Kahn, D. A., Kaplan, A. P., Katelaris, C., Maurer, M., Sim Park, H., Potter, P., Saini, S., Tassinari, P., Tedeschi, A., Min Ye, Y., Zuberbier, T., and the WAO Scientific and Clinical Issues Council: Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ. J. 2012: 5; 125-147. IF: N/A |
r.067
Urticaria and Angioedema across the ages
159. | Saini, S., Shams, M., Bernstein, J. A., and Maurer, M.+: Urticaria and Angioedema across the ages. J. Allergy Clin. Immunol. Pract. 2020: 6; 1866-1874. IF: 8.86 |
r.159
Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria
124. | Sánchez-Borges, M., Caballero-Fonseca, F., Capriles-Hulett, A., González-Aveledo, L., and Maurer, M.: Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 964-971. IF: 4.29 |
r.124
Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus
208 | Hawro, T., Bogucki, A., Krupińska-Kun, M., Maurer, M.+, and Woźniacka, A.: Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS ONE 2015: 10; e0119911. IF: 3.05 |
o.208
Rupatadine in allergic rhinitis and chronic urticaria
22. | Mullol, J., Bousquet, J., Bachert, C., Canonica, W. G., Gimenez-Arnau, A., Kowalski, M. L., Marti-Guadano, E., Maurer, M., Picado, C., Scadding, G., and van Cauwenberge, P.: Rupatadine in allergic rhinitis and chronic urticaria. Allergy 2008: 63; 5-28. IF: 6.20 |
Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm
123. | Vena, G. A., Maurer, M., Cassano, N., and Zuberbier, T.: Alternative treatments for chronic spontaneous urticaria beyond the guideline algorithm. Curr. Opin. Allergy Clin. Immunol. 2017: 17; 278-285. IF: 3.54 |
r.123